Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fate Therapeutics (FATE) Interest Coverage Ratio (2016 - 2019)

Fate Therapeutics' Interest Coverage Ratio history spans 7 years, with the latest figure at 48.46 for Q4 2019.

  • For Q4 2019, Interest Coverage Ratio fell 25.64% year-over-year to 48.46; the TTM value through Sep 2020 reached 206.27, down 284.59%, while the annual FY2019 figure was 55.96, 41.79% down from the prior year.
  • Interest Coverage Ratio reached 48.46 in Q4 2019 per FATE's latest filing, up from 67.8 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 11.26 in Q3 2015 to a low of 67.8 in Q3 2019.
  • Average Interest Coverage Ratio over 5 years is 33.77, with a median of 34.11 recorded in 2018.
  • Peak YoY movement for Interest Coverage Ratio: surged 94.06% in 2015, then plummeted 131.08% in 2017.
  • A 5-year view of Interest Coverage Ratio shows it stood at 11.26 in 2015, then crashed by 106.62% to 23.26 in 2016, then dropped by 27.74% to 29.72 in 2017, then fell by 29.8% to 38.57 in 2018, then dropped by 25.64% to 48.46 in 2019.
  • Per Business Quant, the three most recent readings for FATE's Interest Coverage Ratio are 48.46 (Q4 2019), 67.8 (Q3 2019), and 58.89 (Q2 2019).